story of the week
Glucose-Lowering Drugs to Reduce CVD Risk in T2D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
N. Engl. J. Med 2021 Apr 01;384(13)1248-1260, RR KalyaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.